Sotac Pharmaceuticals Limited (NSE:SOTAC)
India flag India · Delayed Price · Currency is INR
128.50
0.00 (0.00%)
At close: Oct 23, 2025

Sotac Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212020
Period Ending
Oct '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
1,4141,3121,337---
Upgrade
Market Cap Growth
-1.99%-1.86%----
Upgrade
Enterprise Value
1,8831,6251,578---
Upgrade
Last Close Price
128.00118.65120.90---
Upgrade
PE Ratio
17.6316.3531.23---
Upgrade
PS Ratio
1.411.311.29---
Upgrade
PB Ratio
2.422.252.71---
Upgrade
P/TBV Ratio
2.762.563.09---
Upgrade
EV/Sales Ratio
1.881.621.52---
Upgrade
EV/EBITDA Ratio
11.119.5817.90---
Upgrade
EV/EBIT Ratio
14.3512.3827.59---
Upgrade
Debt / Equity Ratio
0.750.750.501.121.126.67
Upgrade
Debt / EBITDA Ratio
2.582.582.822.900.9311.78
Upgrade
Debt / FCF Ratio
----2.60-
Upgrade
Asset Turnover
0.870.871.161.422.091.50
Upgrade
Inventory Turnover
3.573.575.036.0210.9511.02
Upgrade
Quick Ratio
0.700.700.690.550.450.31
Upgrade
Current Ratio
1.361.361.391.030.940.76
Upgrade
Return on Equity (ROE)
17.22%17.22%10.37%17.38%62.65%-64.97%
Upgrade
Return on Assets (ROA)
7.14%7.14%4.00%6.10%12.24%-2.19%
Upgrade
Return on Capital (ROIC)
9.30%9.30%6.17%11.92%25.41%-3.76%
Upgrade
Return on Capital Employed (ROCE)
18.00%18.00%9.30%19.10%89.60%-
Upgrade
Earnings Yield
5.67%6.12%3.20%---
Upgrade
FCF Yield
-15.09%-16.27%-25.33%---
Upgrade
Dividend Yield
0.08%0.08%----
Upgrade
Payout Ratio
----15.98%-
Upgrade
Buyback Yield / Dilution
-0.67%-0.67%-36.35%---132.16%
Upgrade
Total Shareholder Return
-0.59%-0.59%-36.35%---132.16%
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.